Press releases
- BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS
- BIO-TECHNE DECLARES DIVIDEND
- BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS
- BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC
- BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
- BIO-TECHNE SURPASSES 10,000 PEER-REVIEWED PUBLICATIONS CITING RNAscope TECHNOLOGY
- BIO-TECHNE TO PRESENT AT THE 2024 AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR) CONFERENCE
- BIO-TECHNE RECEIVES CiteAb'S ELISA KIT SUPPLIER OF THE YEAR AND SPATIAL BIOLOGY INNOVATION AWARDS
More ▼
Key statistics
As of last trade Bio-Techne Corp (T1CH34:SAO) traded at 11.22, -21.15% below its 52-week high of 14.23, set on Aug 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 11.22 |
---|---|
High | 11.22 |
Low | 11.22 |
Bid | 12.91 |
Offer | 12.99 |
Previous close | 11.22 |
Average volume | 12.33 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Annual div (ADY) | 0.0371 BRL |
---|---|
Annual div yield (ADY) | 0.33% |
Div ex-date | Feb 08 2024 |
Div pay-date | Mar 01 2024 |
Data delayed at least 15 minutes, as of May 03 2024 15:04 BST.
More ▼